Treatment of complicated urinary tract infection and acute pyelonephritis by short-course intravenous levofloxacin (750 mg/day) or conventional intravenous/oral levofloxacin (500 mg/day): prospective, open-label, randomized, controlled, multicenter, non-inferiority clinical trial

OBJECTIVE: To compare the efficacy and safety of short-course intravenous levofloxacin (LVFX) 750 mg with a conventional intravenous/oral regimen of LVFX 500 mg in patients from China with complicated urinary tract infections (cUTIs) and acute pyelonephritis (APN). METHODS: This was a prospective, o...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Hong, Li, Xiao, Ni, Zhao-Hui, Niu, Jian-Ying, Cao, Bin, Xu, Jie, Cheng, Hong, Tu, Xiao-Wen, Ren, Ai-Min, Hu, Ying, Xing, Chang-Ying, Liu, Ying-Hong, Li, Yan-Feng, Cen, Jun, Zhou, Rong, Xu, Xu-Dong, Qiu, Xiao-Hui, Chen, Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2017
Materias:
Nephrology - Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5321781/
https://www.ncbi.nlm.nih.gov/pubmed/28108978
http://dx.doi.org/10.1007/s11255-017-1507-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5321781/
https://www.ncbi.nlm.nih.gov/pubmed/28108978
http://dx.doi.org/10.1007/s11255-017-1507-0

Ejemplares similares